Oct 22, 2015

Pulsed Electromagnetic Field Therapy for Cancer and Pain

An FDA-Approved Cancer Treatment Novocure™ has a new FDA-approved weapon (NovoTTF-100A System™) for patients and physicians in the battle against cancer (specifically for treating recurrent brain tumors). Microcurrent therapy is a novel anti-mitotic treatment that has been shown to slow or reverse tumor progression by inducing cell death in certain solid tumors. Their microcurrent device …

Proceed to the page: http://linkis.com/jCVsr

Similar Articles Added Earlier

  • Bristol-Myers' gets early approval of combo cancer treatment

    TRENTON, N.J. (AP) — The first combination of breakthrough drugs that boost the immune system to fight cancer has been approved, giving maker Bristol-Myers Squibb Co. an early lead over competitors testing other combos in a pharmaceutical gold rush of sorts. The Food and Drug Administration gave...

  • FDA OKs breakthrough cholesterol drug for high-risk patients

    WASHINGTON (AP) — The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades. The drug from Sanofi and Regeneron Pharmaceuticals Inc. offers an important new option for millions of...

  • Innovative vaccine therapy shows promise against glioblastoma brain tumors

    An innovative vaccine therapy developed at Roswell Park Cancer Institute is being tested in a multisite clinical trial involving 50 patients with newly diagnosed glioblastoma brain tumors. The phase II study, now accruing patients at both Roswell Park and the Cleveland Clinic, will assess the...

  • Recurrent ovarian cancer patients may have hope | Harvard Gazette

    Gene therapy inhibited chemoresistant tumor growth in animal model | Harvard researchers have found a gene therapy that delivers a protein that suppresses the development of female reproductive organs. This new treatment could improve the survival of patients with ovarian cancer that has recurred...

  • FDA-Approved Treatment Could Be Effective Against Drug-Resistant Brain Tumors In Children | IFLScience

    Scientists have found a new way to control an overactive Hedgehog. But we’re not talking about slipping small prickly mammals a chill pill. Hedgehog, in this instance, refers to a cellular signaling pathway (yes, part of it is even called Sonic hedgehog, whatever keeps scientists amused) that can...

Latest Links Processed

0/120